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ABSTRACT
EFFECTS OF INTERMITTENT PNEUMATIC COMPRESSION ON LEG BLOOD
FLOW AND VASCULAR FUNCTION AFTER SPINAL CORD INJURY
by Lena Marie Cialdella
May 2016
Intermittent pneumatic compression (IPC) can increase leg blood flow (BF) in
able-bodied persons. Whether IPC can alter leg BF and improve vascular function in
people with SCI is currently unknown. PURPOSE: To test the hypothesis that acute IPC
will increase leg BF, and improve vascular function in SCI. METHODS: Participants
(n=8; injury level: T3 and below; A.S.I.A. class A-C; age: 41±17 yrs) were recruited for a
1-hour IPC session performed in one leg (experimental leg; EXP), with the other serving
as a control (CON). IPC consisted of sequential, foot-to-calf compressions (4-s inflate,
16-s deflate; 3 compressions/min). Posterior-tibial artery BF (Doppler-ultrasound) was
examined at rest, and at 15 and 45 mins of IPC. Vascular function was assessed using the
flow-mediated dilation approach (FMD) before and after IPC. RESULTS: Resting
posterior-tibial artery diameter, BF, FMD% and FMD normalized to shear area-undercurve (FMD%/AUC) were similar between legs at rest. A two-way repeated measures
ANOVA (leg x time) revealed that during IPC, BF tended to increase (P=0.063) in EXP
leg (8±2 to 11±3 mL/min at 15 mins; +42±23%), with no change occurring in the CON
leg (9±4 to10±5 mL/min at 15 mins). No main effects were noted for FMD following
IPC; however, 7 of 8 subjects demonstrated increases in FMD%/AUC for EXP leg
(+89±55% improvement; P=0.095, d= 0.362). CONCLUSION: Though no statistical
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difference was found, there were notable effect sizes reported, thus giving the study
further explanation of merit.
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CHAPTER I
INTRODUCTION
More than a quarter of a million Americans are currently living with a spinal cord
injury (SCI), with approximately 12,000 new cases occurring each year (National
Institute of Neurological Disorders and Stroke [NINDS], 2015). These individuals also
have a considerably higher pre-mature death rate (228%) compared to able-bodied (AB)
individuals, which is largely attributable to cardiovascular and metabolic diseases (Groah
et al., 2012; Myers, Lee, & Kiratli, 2007; Sabatier et al., 2006). Furthermore, the lifetime
cost for an individual living with SCI in the U.S. is estimated to be >$3 million, with
annual expenses for SCI treatment across the nation being >$9 billion each year (National
Spinal Cord Injury Statistic Center [NSCISC], 2015). This presents a major, albeit
potentially modifiable, public health challenge.
Increased cardio-metabolic risk after SCI stems from unhealthy body composition
changes (i.e., loss of muscle and bone mass and increased fat mass), along with
impairments in vascular health, particularly in the legs (Hitzig, Miller, Eng, &
Sakakibara, 2012; Myers et al., 2007; Phillips & Krassioukov, 2015; West, Alyahya,
Laher, & Krasioukov, 2013). Importantly, vascular dysfunction precedes the
development of numerous chronic disease states, including ischemic heart disease, type 2
diabetes mellitus, and stroke (Grundy et al., 1999; Libby, Ridker, & Maseri, 2002;
Thijssen et al., 2012). Therefore, strategies sought to improve vascular function in SCI
are vital to improving the cardio-metabolic health profile and reducing premature
mortality in this population.
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In AB individuals, vascular function is maintained through regular elevations in
blood flow induced shear stress which occur during walking and other forms of physical
activity. Shear stress, which represents the frictional force of blood moving across the
vascular endothelium, stimulates endothelial-derived vasodilators, most notably, nitric
oxide, which promote smooth muscle relaxation and increased blood flow to the
physically active region (Thijssen et al., 2009). Nitric oxide also performs a myriad of
anti-atherogenic functions and is considered the most important molecule governing
endothelial health (Green, Jones, Thijssen, Cable, & Atkinson, 2011).
Due to paralysis of the lower extremities, individuals with SCI cannot voluntarily
engage the lower-body. Wheelchair operation, as well as adapted physical activities (e.g.,
wheelchair basketball, quad rugby, and adapted tennis) provide the SCI individual an
opportunity to engage the upper-body, which in turn provides some beneficial systemic
effects on cardio-metabolic health outcomes, such as reducing traditional risk factors of
cardiovascular disease (CVD), such as blood lipid levels, and indices of body
composition (Myers et al., 2007; Phillips et al., 2015; Totosy de Zeptnek, Ditor, Au, &
MacDonald, 2015). However, the vasculature of the lower extremities still remain
vulnerable to pathology (Credeur, Stoner, & Dolbow, 2016). The legs of individuals with
SCI can be exercised via functional electrical stimulation (FES). This technology works
by sending electrical impulses via leads placed on the quadriceps, hamstring, buttocks,
and calf muscles, in a sequence which allows an individual with paralysis to perform leg
ergometry exercise (Kressler, Ghersin, & Nash, 2014). Importantly, FES cycling use has
been shown to be effective in improving body composition and leg vascular function with
regular use (Griffin et al., 2009; Stoner, Sabatier, Mahoney, Dudley, & McCully, 2007).
2

Unfortunately, FES cycles are expensive (~$20,000) and a physician’s prescription is
required for use, making this technology not readily accessible to a majority of
individuals with SCI.
Recent evidence demonstrates that intermittent pneumatic cuff compression (IPC)
applied to the calf and foot can also acutely increase blood flow and shear stress in leg
arteries of able-bodied individuals (Sheldon et al., 2012). IPC is a non-invasive FDA
approved therapy commonly used to treat individuals with symptoms of venous
insufficiency and claudication pain in peripheral arterial disease (Chang et al., 2012;
Roseguini et al., 2012; Sheldon, Roseguini, Laughlin, & Newcomer, 2013). This therapy
is performed by inflating and deflating pneumatic cuffs, which are secured around the
calf and foot region, in regular intervals for a period of time (i.e., 1 hour, 3 inflation
cycles/minute) to simulate the mechanical compression of muscle contractions. While the
use of IPC in clinical AB populations has been extensively tested (Delis, Azizi, Stevens,
Wolfe, & Nicolaides, 2000a; Delis et al., 2000b; Labropoulos et al., 2005; Manfredini et
al., 2014; Roseguini et al., 2012; van Bremmelen, Char, Giron, & Ricotta, 2003), the
efficacy of its use for improving vascular health in individuals with SCI is currently
unknown.
Therefore, the purpose of this study was to determine whether a single IPC
session can acutely enhance blood flow and vascular function in the lower limbs of those
with SCI. We hypothesized that a single session of IPC will transiently increase blood
flow and shear rate, thus, providing an acute enhancement in vascular endothelial
function of lower extremity arteries in people with SCI.
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CHAPTER II
METHODS
Experimental Design
This study consisted of a pre-test with multiple post-tests intervention control
group experimental design.
Subjects
Eight subjects with chronic SCI participated in this study. Subjects were recruited
from the surrounding Hattiesburg and Gulfport, MS area. Following a detailed
explanation of the experimental measures and protocols, each subject provided written
informed consent prior to participating in any facet of the study. Inclusion for
participation consisted of the following: ≥2 years post spinal injury; T3 neurological
injury level and below; American Spinal Injury Association (ASIA) classification A, B
and C; wheelchair reliant; 18-75 years of age. Exclusion criteria consisted of pressure
wounds on the buttocks or feet, unhealed bone fractures or history of fragility fractures,
severe osteoporosis (T-score of -4 or less), uncontrolled autonomic dysreflexia, unstable
cardiovascular or metabolic disease, and <2 years post spinal injury. All experimental
procedures and protocols conformed to the Declaration of Helsinki and were approved by
the University of Southern Mississippi Institutional Review Board (Appendix A).
Experimental Measurements
Cardiovascular Measures. Subjects were instrumented with a lead II surface
electrocardiography (ECG) (Logiq P5; GE Medical systems, Milwaukee, WI, USA) for
continuous measurement of heart rate (HR), and blood pressure (BP) was measured via
automated sphygmomanometry (Omron HEM907XL- Intellisense) performed on the
4

right upper-arm periodically during the experimental protocol. Posterior-tibial artery
diameter and blood velocity signals were obtained using a high resolution (30 Hz)
duplex-Doppler ultrasound system (Logiq P5; GE Medical systems, Milwaukee, WI,
USA). The artery was imaged 3-5 cm superior to the calcaneus and ~1 cm posterior to the
medial malleolus on the right and left ankles, separately, using an 11-MHz linear array
transducer. Diameter and blood velocity signals were obtained simultaneously in duplex
mode, operating at a pulsed Doppler frequency of 5-MHz. Measurements were performed
with the velocity cursor placed mid-vessel and the sample volume was adjusted to
encompass the entire vessel lumen without extending beyond it. To ensure consistency
and stability in the measurement, probe placement was marked on the skin using a
permanent marker, and the transducer was stabilized using a custom-designed clamp. In
addition, all probe settings were kept consistent for each limb throughout the study.
Body Composition Measures. Height was determined with a standard tape
measure with the subject in a supine position. Every effort was made to extend the knee
fully for precise measurement. Weight was determined through the use of a wheelchair
scale (Scale Tronix). Subjects were weighed while in their wheelchair, after which they
were transferred to the examination table using a mechanical lift (Invacare), then the
wheelchair weighed separately. Dual-Energy X-Ray Absorptiometry (DEXA) (Lunar
Prodigy Advance) was performed to determine total body and regional lean and fat mass,
%-body fat (%BF), and total body bone mineral density (BMD). Importantly, T-scores
for BMD were used to determine possible osteopenia and osteoporotic values. To do this,
subjects were transferred from their wheelchair, via the mechanical lift, and positioned
supine on the DEXA scanner. Their legs were strapped proximal and distal to the knees
5

to steady the distal femur and proximal tibia, with a slight internal rotation of the hips to
position the greater trochanter in the best scanning position, and for the safety of the
participant in the event of an untimely muscle spasm (Charmetant, Phaner, Condemine,
& Calmels, 2010; Shields, Schlechte, Dudley-Javoroski, Zwart, & Clark et al., 2005).
Experimental Protocol
Study Visits
Screening Study Visit. On the first day, subjects provided written informed
consent (Appendix B), and completed a detailed medical history questionnaire (Appendix
C), and a leisure time physical activity questionnaire for people with spinal cord injury
(LTPAQ-SCI)© (Ginis, Phang, Latimer, & Arbour-Nicitopoulos, 2010) (Appendix D). A
familiarization session was then performed to acquaint subjects to the experimental
measurements (i.e., Doppler-Ultrasound, and mechanical lift), and to ensure quality
ultrasound images could be obtained. The leg that provided the best quality image served
as the experimental leg (EXP) and the other leg served as the control (CON). Following
the vascular screening, anthropometric measures and the DEXA scan were performed.
For convenience, some subjects completed all facets of the study in a single visit.
Experimental Study Visit. Study visit two consisted of the experimental visit
(Figure 1). All subjects reported to the laboratory during the morning hours (6:00 – 11:00
am) following an overnight fast. Subjects also refrained from caffeine and alcohol for 12
hours, and any strenuous physical activity for 24 hours. After providing a review of the
experimental procedures, the subjects were then transferred to the examination table
using the mechanical lift, positioned semi-recumbent, and instrumented for ECG, BP, and
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Doppler-Ultrasound measurements. Subjects rested quietly for 30 minutes before baseline
testing was performed.
1.

2.

3.

Subject
30 min rest
arrival;
Instrumentation
•
•
•

Duplex
Doppler-US
Baseline
Measures
ECG, BP, BF,
and FMD test
on both legs

•

•
•

IPC intervention •
(60 min) in 1
leg, other leg
control (CON)
•
BF measured at
15- and 45-mins •
during IPC
ECG and BP
monitored
periodically

FMD tests
repeated on
both legs
EXP leg
examined first
Data backed-up
and analyzed
off-line

Figure 1. Timeline for the experimental study visit.
Vascular Function Testing. All testing was performed in a dimly lit, temperature
(22-23° Celsius) and humidity (~50%) controlled room. Following 30 minutes of semirecumbent rest, vascular function was assessed in both posterior-tibial arteries by the
same ultrasonographer. The rationale for choosing this artery stems from previous
evidence suggesting that the posterior-tibial artery experiences a lesser degree of atrophy
following traumatic SCI, as compared to larger vessel of the leg (e.g., popliteal and
femoral arteries) (Stoner et al., 2007). Furthermore, examining the posterior-tibial artery
was a unique aspect, given that it permitted the assessment of vascular changes within the
region of compression, in contrast to a more proximal vessel (i.e., popliteal).
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Vascular endothelial function testing was performed using the Flow-Mediated
Dilation (FMD) technique, in accordance with previously published guidelines (Corretti
et al., 2007; Thijssen et al., 2010). After the attainment of a quality ultrasound signal, two
minutes of baseline data were recorded, followed by inflation of a proximally placed
pneumatic cuff (220 mmHg) (Hokanson; Bellevue, WA), positioned ~1 cm distal from
the fibular head around the subject's calf, for 5 minutes. Data were recorded continuously
from the last 30 seconds of occlusion and until 4 minutes post cuff-release using an
image capturing system (El Gato), and analyzed off-line via an automated edge-detecting
software (QUIPU, FMD Studio) by the same study personnel, separate from the
ultrasonographer. The 3 largest diameter values following cuff-release were averaged and
considered the peak change, and used to calculate FMD as described under Data Analysis
below. Baseline posterior-tibial artery FMD measurements were randomized between
limbs, and were separated by at least 10 minutes. Absolute blood flow (BF in mL/min)
data were also recorded and analyzed off-line on the Doppler Ultrasound unit (GE, Logiq
P5). It is important to note, that while between-day reliability was not performed on SCI
individuals for this study, previous work has reported good day-day reliability of
posterior-tibial artery FMD in AB individuals (Black, Cable, Thijssen, & Green, 2008).
Furthermore, the stability of this measurement was examined after 60 minutes of quiet
rest in SCI individuals (n=2), and importantly, no apparent differences were noted for
posterior-tibial artery FMD% (e.g., baseline = 29±11%, vs. 60 mins rest=33±9%).
Intermittent Pneumatic Compression. To best administer IPC, the same rapid
inflation system used during vascular endothelial function testing, was also used to
administer the intervention. To do this, two separate cuffs, one small cuff (SC5; 5 cm
8

bladder) positioned around the mid-foot and another larger cuff (CC17; 17 cm bladder)
positioned around the calf (~1 cm distal to the fibular head) of the EXP leg, were
connected to a single inflation unit (Hokanson E20-Rapid Cuff Inflator). During inflation,
the foot cuff always inflated first (~0.5 second delay), followed shortly by the calf cuff,
thus, providing a sequential foot-to-calf compression cycle, similar to that of a
commercially available IPC device (e.g., ArtAssist®). In addition, the Hokanson cycle
timer was adjusted to deliver three automated compressions per minute (4-s inflation/ 16s deflation) at 120 mmHg, over the course of an hour. Traditional IPC therapy (e.g.
ArtAssist®) consists of 3-s inflation/ 15-sec deflation (Sheldon et al., 2012). The
rationale for the timing adjustment in the current study was to account for an approximate
1-s delay in the Hokanson inflation unit reaching the desired pressure. For proof of
concept, we examined popliteal artery BF responses to 5 minutes of IPC therapy between
this experimental (Hokanson) vs. traditional (ArtAssist®) IPC approach in one AB
participant, and importantly, no marked differences were noted for the magnitude of
initial increase (% mL/min) between devices (e.g., Hokanson=+166% vs. ArtAssist=
+161%).
Hemodynamics during IPC. To examine the hemodynamic profile, posterior-tibial
artery blood velocity signals (antegrade and retrograde velocity) were acquired on both
the Doppler-ultrasound and image capture software, as described in detail above. Three
compression cycles (~1 minute of data), were recorded at baseline, and following minutes
15 and 45 of IPC. Following 60 minutes of IPC therapy, the FMD tests were repeated in
both legs. In order to detect the transient changes in vascular endothelial function, the
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order of FMD tests was not randomized, and the EXP leg was always assessed
immediately following completion of IPC (~3 mins post treatment).
Analysis
Data Analysis
All ultrasound data were outsourced at 30-Hz, and acquired onto a designated
laptop (Mac Book) using a commercially available analog video capture unit (El Gato).
Data were then analyzed off-line, in accordance with guidelines (Thijssen et al., 2010),
by playing pre-recorded videos through the Cardiovascular Suite software. A region of
interest (ROI) was selected on each video to ensure a clear portion for the edge-detection
software to analyze posterior-tibial artery diameters. Blood velocity signals were also
simultaneously analyzed using the same software by obtaining the flow-envelope (area
under tracing) for both the antegrade (positive area) and retrograde (negative area)
velocity signals. Mean velocity was defined as the difference between antegrade and
retrograde velocity signals. Blood flow (mL/min) was calculated as;
(π*diameter/2)2*mean velocity*60. Blood flow was also analyzed on the Duplex
Doppler-ultrasound using internal software (GE) in addition to analyses performed on the
Cardiovascular Suite software.
To determine BF and shear rate responses during IPC, velocity signals were
analyzed and averaged between compression cycles in order to minimize any potential
artifact from movement due to cuff inflation/deflation. Vascular endothelial function was
determined as the peak change in posterior-tibial artery diameter from baseline following
cuff release, and expressed in both absolute (mm) and relative (%) terms; i.e., FMD
change=(peak diameter-baseline diameter)/baseline diameter*100. Shear rate (s-1) was
10

calculated as 8*mean velocity/diameter (van Brussel, F, van Brussel, B, Hoeks, Roodt, &
Henry et al., 2015) and shear rate incremental area-under-the-curve (AUC) up until the
time (sec) peak diameter was calculated using the trapezoidal method (i.e., change in
shear rate/second), and importantly, was used to normalize FMD% to the stimulus
(FMD%/AUC) (Padilla et al., 2008; Thijssen et al., 2012).
Statistical Analysis
To examine differences between vascular function, and blood flow (BF) indices at
rest, during, and after IPC therapy, separate 2-way (leg x time) repeated measures
ANOVA’s were performed. Bonferroni post hoc tests were selected to examine possible
interactions between study measurements. Independent sample T-tests were utilized to
compare relative changes in BF and vascular function between legs (EXP vs. CON), pre
and post IPC therapy. Cohen’s d effect sizes were also calculated to examine
meaningfulness of changes in vascular function and BF between legs, pre to post IPC
therapy. All statistical analyses were performed using Sigma Plot Analysis software and
SPSS (IBM, Watson Analytics). Statistical significance was set a priori at p<0.05, and
moderate to large effect sizes were considered clinically meaningful.
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CHAPTER III
RESULTS
Subject Data
Individual participant demographics are summarized in Table 1. The average age
and duration of SCI was 41±6 years and 20±19 years, respectively. Within the cohort,
three subjects had diagnosed metabolic disease (type 2 diabetes), and one had a history of
cardiovascular complications (coronary artery disease). Importantly, all subjects were
asymptomatic at rest and no differences were noted between the participant’s responses
pre and post IPC, as compared to the cohort.
Table 1
Subject Demographics
Subject

Age
(yrs)

Sex

Race Ht. (m) Wt. (kg)

%BF

BMD

1

27

M

C

1.9

2

53

M

C

3

36

M

4

75

5

T-score Injury SCI ASIA
Level (yrs) class

103.8

34

1.42

2.5

T-5

9

A

1.8

85.3

40

1.34

1.4

T-12

34

B

C

1.5

50.5

19

1.08

-1.7

T-6

21

A

M

C

1.8

79.5

35

1.12

-1.2

T-3,4

60

B

34

F

AA

1.6

109.5

60

1.12

-0.1

T-10

13

B

6

33

M

AA

1.8

131.6

42

1.45

2.9

T-9

10

A

7

30

F

C

1.5

60.2

32

1.07

-0.7

T-11

10

C

8

35

M

AA

1.7

126.5

45

1.51

3.7

T-12,

2

A

L-1

Avg±Sd 41±16

1.7±0.1 93±26

38±11 1.3±0.2

20±19

Note. C (Caucasian), AA (African American), %BF (body fat percentage), BMD (bone mineral density), ASIA class (American
Spinal Injury Association) classification scale.

12

Hemodynamic Responses to IPC
Table 2 summarizes hemodynamic data at rest, and during IPC for both legs.
Figure 2 represents a Doppler-Ultrasound image from one subject showing BF at baseline
and following 15 mins of IPC in the EXP leg. Although not statistically significant, a
majority of subjects demonstrated a biphasic pattern for BF and shear rate responses to
IPC in the EXP leg (n=6), characterized by a transient increase (~50%) at 15 mins, with a
return to baseline at 45 mins. When comparing peak Δ% in BF during IPC, occurring at
either 15 or 45 mins, the EXP leg tended to show a positive response (+42±23%,
P=0.063, d=0.27), with no change observed in the CON leg (-7±15%) (Figure 3). To
note, CON leg BF data were not collected in one subject due to physical limitations (i.e.,
history of blood clots in that leg).
Table 2
Hemodynamic Variables at rest and during IPC
EXP Leg

CON Leg

HR (bpm)

Rest
70±10

15mins
67±11

45mins
66±4

Rest
70±10#

15mins
67±11#

45mins
66±4#

MAP (mmHg)

90±5

91±9

90±11

90±5#

91±9#

90±11#

Diameter (cm) 0.17±0.01 0.17±0.05 0.17±0.007
Mean Velocity(cm/sec)

0.16±0.1 0.16±0.2

6.6±2.0

5.0±1.1

7.7±2.7

7.1±3.2

8.0±2.4 10.7±3.2

6.6±1.5

9.0±3.5

10.2±5.2 10.0±5.1

Ant Shear (s-1) 254 ±111 258±141

215±85

304±209

298±265 272±200

Ret Shear (s-1)

-39±34

-28±27

BF (ml/min)

6.3±1.2

0.15±0.2

-39±37

-37±35

Mean Shear (s-1) 215±125 221±150

178±89

-28±37

6.6±2.8

-28±37

274±226 270±280 245±214

Note: HR (Heart Rate), MAP (Mean Arterial Pressure), BF (Blood Flow), Ant (Antegrade), Ret (Retrograde). #same data as EXP leg.
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A)

B)

Figure 2. Blood Flow Response after 15 minutes of IPC. Image is a representation of
blood flow responses to IPC as seen on the Duplex Doppler-ultrasound. Panels A) and B)
depict the blood flow pattern of the same participant at baseline, and after 15 minutes of
IPC in the EXP leg, respectively. Note the approximate 50% increase in mean velocity as
shown by the bottom sweep in each panel

Blood Flow (ml/min)

16

Baseline
15 mins
45IPC
mins
IPC

Limb: P=0.901
Time Point: P=0.203
Interaction: P=0.138

B)

12

8

4

EXP
Leg

P=0.063
80

Blood Flow Peak %Δ

A)

60
40
20
0

EXP

CON
Leg

CON

Figure 3. Blood Flow Response during IPC. Panel A) depicts blood flow measures
during IPC in the EXP leg and CON leg. Panel B) depicts the percent change (%Δ) of
peak blood flow between the EXP and CON leg, respectively.
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Vascular Endothelial Function Responses to IPC
Table 3 summarizes results from FMD testing before and after IPC therapy for
both the EXP (n=8) and CON (n=6) leg. Of note, FMD testing was not performed on the
CON leg in two subjects due to physical limitations (n=1), and an inability to obtain
optimal image quality for analysis (n=1).
Table 3
Vascular Endothelial Function before and after IPC
EXP pre

EXP post

CON pre

CON post

Base Diam. (cm)

1.7 ± 0.1

1.7 ± 0.1

1.5 ± 0.1

1.6 ± 0.1

Peak Diam. (cm)

2.2 ± 0.1

2.3 ± 0.1

2.0 ± 0.2

2.0 ± 0.2

Abs. Δ (mm)

0.4 ± 0.1

0.5 ± 0.1

0.5 ± 0.1

0.3 ± 0.1

%Δ

24.7 ± 4.0

32.8 ± 7.8

30.6 ± 3.6

21.9 ± 5.3

Peak Shear (s-1)

648 ± 57

603 ± 69

493 ± 120

469 ± 113

18481 ± 3448

15398 ± 2201

15971 ± 6001

14221 ± 3945

Shear AUC

Note: Diam. (Diameter), Abs. (Absolute), AUC (Area under Curve)

Figure 4 represents individual data responses for normalized FMD pre and post
IPC for both legs. For FMD%/AUC, no statistical differences were noted for changes
between the EXP and CON leg, pre- and post-IPC. However, when these data were
expressed as a change score (%Δ) (Figure 5), the EXP leg tended to show an
improvement in a majority of subjects (+89±55%, P=0.095; effect size d= 0.362), with no
change occurring in the CON leg (-21±21%).
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FMD%/AUC

Limb: P=0.120
Time Point: P=0.606
Interaction: P=0.261
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CON Leg
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0
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BL

Post-IPC

Post-IPC

Figure 4. Normalized FMD Response for Individual Data pre- and post-IPC. This graph
depicts individual and mean summary data for FMD%/AUC at baseline and 60-minutes
post-IPC for the EXP and CON leg.

P=0.095

FMD%/AUC %Δ

150
100
50
0

EXP Leg

CON Leg

Figure 5. Improvement in Vascular function following IPC. Graph represents the percent
improvement (%Δ) in FMD%/AUC between EXP and CON legs following 60 mins IPC.
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CHAPTER IV
DISCUSSION
This study sought to determine the efficacy of a novel therapy, IPC, in targeting
leg blood flow and vascular function in people with SCI. Uniquely, we show for the first
time, that IPC can be implemented safely in paralyzed legs of people with paraplegic
SCI. Contrary to our initial hypotheses, there were no significant main effects of IPC to
increase blood flow, or to improve vascular function. However, there was a tendency for
a majority of subjects to show positive effects on these study outcomes. Collectively,
these preliminary data demonstrate that one hour of IPC therapy may acutely increase leg
blood flow, and improve vascular function in some people with SCI.
Leg Blood Flow
Effects of IPC on Leg Blood Flow
Previous research has demonstrated that IPC can transiently increase arterial BF
and shear rate when applied to the lower legs of AB individuals. For example, one study
reported that popliteal artery BF and shear rate increased two-fold within the first 15 mins
of IPC (Sheldon et al., 2012). In other studies, IPC significantly increased popliteal artery
inflow in patients with peripheral vascular disease (Delis et al., 2000a), as well as altered
popiteal venous outflow in tetraplegic SCI subjects (Nash, Mintz, Montalvo, & Jacobs,
2000). Uniquely, for the first time, we examine posterior-tibial artery BF responses to
IPC in paraplegic SCI subjects. In this study, no significant main effects were noted for
IPC to alter leg BF and shear rate in people with SCI. One potential explanation for the
lack of agreement between our data and others could be attributed to the artery chosen to
undergo Doppler-ultrasound scanning, which was the posterior-tibial artery near the
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ankle. Because of its location (i.e., between compression cuffs), it is possible that the
hyperemic stimulus to IPC may have been dampened, thus, reducing our ability to
examine a measurable effect on conduit artery blood flow. Interestingly, our data did
show a tendency (P=0.063; d=0.265) for peak increases in blood flow to be greater in the
EXP, as compared to the CON leg. After further examination of these data, we found that
some individuals achieved a peak response within 15 mins (N=6), while others took as
long as 45 mins (N=2) to achieve this peak BF response. Therefore, it is plausible that
some individuals may have reached their peak increase in BF beyond the measurement
intervals (i.e., between 15 and 45 mins). Future work will be needed to further examine
the time course of BF responses to IPC in people with SCI.
While this study was not designed to test mechanisms, a discussion of the
potential contributors to hyperemia following mechanical compression is worth
considering. IPC therapy has been shown to provide a muscle pump-like effect on the
peripheral vasculature (Delis, Nicolaides, Labropoulos, & Stansby, 2000c). Following
application of an external pressure (120 mmHg), the resulting vascular compression
would, in theory, displace venous volume back to the heart, widen the arterial-venous
pressure gradient, and in turn, increase arterial inflow within the stimulated region
(Laughlin, 2005). Repeated compressions could also further elevate arterial inflow
through increased shear stress on the arterial wall, with subsequent production and
release of endothelial-derived vasodilators. For example, IPC performed bilaterally on the
legs in rats has been shown to increase the expression of endothelial derived nitric oxide
synthase—the enzyme catalyzing the reaction to produce nitric oxide—as well as,
stimulate nitric oxide-mediated vasodilation, with subsequent hyperemia within the
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microvasculature of cremaster muscles (Chen et al., 2002; Liu, Chen, Seber, Johnson, &
Urbaniak, 1999). Whether this mechanism plays a role for the hyperemic response to IPC
in humans, warrants further investigation.
Leg Vascular Function
Effects of IPC on Leg Vascular Function
Repetitive increase in shear stress (i.e., dynamic exercise and external peristaltic
pneumatic compression—EPC) have been shown to transiently modulate vascular
endothelial function in healthy AB individuals (Martin, Borges, & Beck, 2015; Padilla,
Harris, & Wallace, 2007). Given this evidence, we posited that IPC could also serve as a
means to enhance leg vascular function in people with SCI. Contrary to this hypothesis,
no significant main effect was noted for IPC to alter vascular function in SCI. This
finding is in agreement with one report demonstrating that acute IPC does not improve
leg vascular function in healthy AB individuals. Our data did show a tendency for FMD
normalized to shear AUC to improve in the EXP leg (P=0.095; d=0.362), with a majority
of individuals exhibiting positive effects (7 out of 8). This leaves the question of whether
IPC may influence vascular function in some individuals with SCI, and not others.
Interestingly, a more recent report indicated that 60 minutes of EPC applied to the legs
can indeed significantly improve leg vascular function (i.e., popliteal artery) in healthy
AB individuals (Martin et al., 2015). It is important to emphasize that this study utilized a
different type of compression stimulus consisting of a sequential distal-to-proximal
pneumatic compression applied to 5 regions on the leg at a lower pressure (i.e., 70 mmHg
compared to 120 mmHg), but different tempo (60-s inflate/30-s deflate, for 1 hour). This
variation of the compression stimulus likely produced their observed improvement in
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vascular function, as opposed to the previous IPC research in AB individuals (Sheldon et
al., 2012). Indeed, future studies are warranted to determine whether alterations in the
IPC stimulus (i.e., number of compression regions, inflation pressure, and duty cycle) can
alter vascular function in people with SCI, as well as AB individuals.
Limitations and Clinical Implications
Experimental Limitations
There are a few experimental limitations that are worth discussing. Our subjects
varied in age (27-75 years), neurological injury level, duration of SCI, and ASIA
impairment, all of which could have confounding influences on study results. Given the
inherent difficulty in matching people with SCI, we had to temper our inclusion criteria
to accept of wide range of individuals to achieve a sufficient sample number. Indeed,
future efforts will be needed to discern whether such factors could play a role in
modulating vascular responses to IPC therapy. Still, with a low sample number, and
heterogeneous SCI group, our data showed tendency and moderate effects for IPC to
increase BF, and improve vascular function in some individuals, which perhaps, warrants
further investigation with a larger, and more homogenous SCI cohort.
Uniquely, our study investigated the posterior-tibial artery which permitted the
examination of vascular changes within the region of compression. However, given this
location, it is possible that the hyperemic stimulus may have been minimized, thus,
reducing our ability to examine a measureable effect. Future research will be needed to
determine whether a more proximal vessel, such as the popliteal artery or femoral artery,
responds differently to acute, and or chronic IPC in people with SCI.
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Clinical Implications
A majority of people with SCI are subjected to prolonged periods on inactivity
due to paralysis below the level of injury. It is well known that physical activity has
positive effects of cardio-metabolic health outcomes (American College of Sports
Medicine, 2014). Interestingly, a recent report indicated that achieving the physical
activity recommendations in SCI through 16 weeks of upper-body exercise does not
provide comparable benefits as AB individuals, in terms of improving cardio-metabolic
health outcomes (Totosy de Zepetnek et al., 2015). Upper-body exercise training alone
may not provide a sufficient stimulus to vulnerable regions, like the paralyzed legs
(Credeur et al., 2016). Therefore, targeting this region with alternative efficacious, and
economically viable therapies may provide a means to further combat cardio-metabolic
health declines, when used alone, or possibly in combination with other traditional
approaches (e.g., FES cycling, and arm ergometry). The exploratory nature of this project
provides evidence to support that external stimuli applied to the paralyzed region may
have beneficial effects in some individuals within our study sample. Therefore, future
research should continue examining whether novel therapies, like IPC, can serve as an
effective means to enhance vascular health outcomes in people living with SCI.
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CHAPTER V
CONCLUSION
In summary, these preliminary data indicate that one hour of IPC therapy can be
implemented safely in the paralyzed legs of people with SCI. While no statistical
differences were noted for study outcomes, a majority of subjects tended to exhibit
positive effects on blood flow (P=0.063; d=0.265) and vascular function (P=0.095;
d=0.362). Therefore, future studies should further evaluate the effects of IPC therapy on
cardio-metabolic health outcomes when performed acutely and chronically in people
living with SCI.
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APPENDIX C
HEALTH HISTORY FORM

University of Southern Mississippi, Laboratory of Applied
Physiology
Medical Health History Form
All of the information provided in this form is voluntary.
Date:
Biographical information:
Last Name:

First:

Occupation:

Email:

Home Phone: (

)

Work: (

)

MI:
Cell: (

)

Address:
DOB:

/

/

Age:

Gender M / F

Height:

Weight:

Highest Education Achieved:
Race:

What race do you consider yourself to be? Select one or more of the following:

Hispanic or Latino - A person of Mexican, Puerto Rican, South or
Central American, or other Spanish culture or origin, regardless of race.
The term "Spanish origin," can be used in addition to "Hispanic or
Latino."

American Indian or Alaska Native - A person having origins in any
of the original peoples of North, South, of Central America, and who
maintain a tribal affiliation or community attachment.

Asian- A person having origins in any of the originals peoples of the Far
East, Southeast Asia, or the Indian subcontinent, including, for example,
Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the
Philippine Islands, Thailand, and Vietnam. (Note: Individuals from the
Philippine Islands have been recorded as Pacific Islanders in the
previous data collection strategies.)

Black or African American - A person having either origins in any of
the black racial groups of Africa. "Haitian" can be used in addition to
"Black" or "African American."

Native Hawaiian or Pacific Islander - A person having origins in
any of the original peoples of Hawaii, Guam, Samoa, or other Pacific
Islands.

White - A person having origins in any of the original peoples of
Europe, the Middle East, or North Africa.
Primary Care Physician:
Name:

Office Phone:

Address:
Emergency Contact:
Name:

Relationship:

Phone #
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Medications: Include over the counter drugs/ oral contraceptive/ dietary supplements
Name/ Dosage/ How often taken:

Allergies:
Smoking History:
Do you smoke

Cigarettes? Pipe/ Cigar? Other? If you quit, what year did you quit?

# of packs smoked per day ________________
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For how many years _________________

Medical Health History Form

Page 2

Alcohol Consumption History:
Do you currently drink alcohol?
If you drank alcohol previously, when did you stop?
If you ever did drink alcohol, what is (was) the volume consumed?
_____________# ounces / day
for _______________ # of years
Medical History:
NO
YES

Please explain any "YES" answers
high blood pressure
chest pain/ history of heart attack
extra heart beats or racing
abnormal electrocardiogram (ECG)
other heart trouble (e.g. murmur, valve problems)
high cholesterol
diabetes
seizures
stroke
fainting spells
anxiety (diagnosed)
depression (diagnosed)
recurrent fatigue
insomnia
thyroid problems
difficulty breathing
emphysema/ asthma/ chronic bronchitis
tuberculosis
chronic infection
stomach/ GI problems
hepatitis
bleeding disorder
kidney/ urinary problems
joint injuries/ joint pain
arthritis (rheumatoid or osteoarthritis)
migraine headaches
vision problems (exclude corrected near/ far sightedness)
surgical procedures
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Medical Health History Form

Page 3

Inclusion Criteria for SCI Participants:
1. Adults with chronic T3 – L5, (AISA- A, B, or C) SCI (2 years post injury)
2. Wheelchair reliant (unable to walk with or without support)
3. Between 18 and 75 years of age
Exclusion Criteria:
1.
2.
3.
4.
5.

No evidence of pressure wounds on buttocks or feet
Unhealed bone fracture or history of low trauma (fragility) fracture
Severe Osteoporosis (T score of -4 or less or a history of fragility fractures)
Uncontrolled autonomic dysreflexia
Less than 2 years post injury

Where is the location of your injury?
How long have you had the diagnosis of SCI?
Injury Questions:
NO

YES

Please explain any “YES” answers
Do you have a history of uncontrolled autonomic dysreflexia?
Have you suffered a bone fracture recently?
Have you been diagnosed with orthostatic hypotension?
Have you been diagnosed with Osteoporosis?
Do you have a history of bone fragility fractures?
Do you have any decubitus ulcers or ulcers on the feet?

Please sign and date:
Signature: __________________________________________________________ Date:
_______________________
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